Pliant Therapeutics Inc (PLRX)

May 02, 2025

Bay Area biotech company slashes staff after losing $655 million in value - SFGATE

May 02, 2025

May 02, 2025

Pliant Therapeutics to cut 45% of workforce (PLRX:NASDAQ) - Seeking Alpha

May 02, 2025

May 01, 2025

Pliant Therapeutics (PLRX) Restructures to Prolong Financial Res - GuruFocus

May 01, 2025

May 01, 2025

Pliant Therapeutics announces workforce reduction By Investing.com - Investing.com India

May 01, 2025

May 01, 2025

Pliant Therapeutics Announces Major Workforce Reduction - TipRanks

May 01, 2025

May 01, 2025

Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations - GlobeNewswire

May 01, 2025

May 01, 2025

Pliant Therapeutics Slashes Nearly Half its Workforce While Awaiting Crucial IPF Drug Results - Stock Titan

May 01, 2025

May 01, 2025

You might want to take a look at Pliant Therapeutics Inc (PLRX) now - Sete News

May 01, 2025

Apr 30, 2025

Pliant Therapeutics Inc [PLRX] stock was sold by Coulie Bernard at the price of US$0.59 million - knoxdaily.com

Apr 30, 2025

Apr 30, 2025

Market Momentum: Pliant Therapeutics Inc (PLRX) Registers a 0.68 Increase, Closing at 1.48 - DWinneX

Apr 30, 2025

Apr 30, 2025

Stock Performance Spotlight: Cg Oncology Inc (CGON) Ends the Day at 26.94, Down by -3.68 - DWinneX

Apr 30, 2025

Apr 30, 2025

Pliant Therapeutics Inc (PLRX)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com

Apr 30, 2025

Apr 28, 2025

Pliant Therapeutics Inc: A Year of Highs, Lows, and Market Resilience - investchronicle.com

Apr 28, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

Apr 25, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant ... - Bluefield Daily Telegraph

Apr 25, 2025

Apr 25, 2025

Pliant Therapeutics discovers new integrin αvβ1, αvβ6 and/or αvβ8 antagonists - BioWorld MedTech

Apr 25, 2025

Apr 25, 2025

Pliant Therapeutics Inc’s Market Journey: Closing Weak at 3.03, Down -1.62 - DWinneX

Apr 25, 2025

Apr 24, 2025

PLRXPliant Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025

Apr 24, 2025

Healthy Upside Potential: Pliant Therapeutics Inc (PLRX) - Sete News

Apr 24, 2025

Apr 24, 2025

Market Recap Check: Pliant Therapeutics Inc (PLRX)’s Positive Finish at 1.54, Up/Down 2.67 - DWinneX

Apr 24, 2025

Apr 23, 2025

Pliant Therapeutics Inc (PLRX)’s stock price in review: A technical analysis - uspostnews.com

Apr 23, 2025

Apr 23, 2025

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Shares Bought by JPMorgan Chase & Co. - Defense World

Apr 23, 2025

Apr 21, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc.PLRX - TradingView

Apr 21, 2025

Apr 10, 2025

PLIANT THERAPT (PLRX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Apr 10, 2025

Apr 09, 2025

Pliant Therapeutics stock hits 52-week low at $1.2 amid sharp decline - Investing.com

Apr 09, 2025

Apr 08, 2025

Pliant Therapeutics stock hits 52-week low at $1.2 amid sharp decline By Investing.com - Investing.com South Africa

Apr 08, 2025

Apr 07, 2025

Major Breakthrough: Pliant Reveals Latest Bexotegrast Research Data in Three Key Presentations - Stock Titan

Apr 07, 2025

Apr 07, 2025

Pliant Therapeutics Announces Upcoming Presentations at the - GlobeNewswire

Apr 07, 2025

Apr 05, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics - ACCESS Newswire

Apr 05, 2025

Apr 03, 2025

Pliant Therapeutics: An Activist On Deck - Seeking Alpha

Apr 03, 2025

Apr 02, 2025

symbol__ Stock Quote Price and Forecast - CNN

Apr 02, 2025

Apr 01, 2025

PLRX stock touches 52-week low at $1.25 amid sharp annual decline - Investing.com Canada

Apr 01, 2025

Mar 28, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Beha - GuruFocus

Mar 28, 2025

Mar 27, 2025

PLRX Stock Plunges 89% in 3 Months: Here's What Investors Should Know - MSN

Mar 27, 2025

Mar 26, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics – PLRX - GlobeNewswire

Mar 26, 2025

Mar 26, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims On Behalf Of Investors Of Pliant Therapeutics – PLRX - menafn

Mar 26, 2025

Mar 23, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant ... - Bluefield Daily Telegraph

Mar 23, 2025

Mar 23, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics - GlobeNewswire Inc.

Mar 23, 2025

Mar 21, 2025

TANG CAPITAL MANAGEMENT LLC Acquires Significant Stake in Pliant Therapeutics Inc - GuruFocus

Mar 21, 2025

Mar 21, 2025

Pliant discontinues Phase 2b/3 trial of IPF treatment bexotegrast - Pulmonary Fibrosis News

Mar 21, 2025

Mar 21, 2025

PLRX Investors Have Opportunity to Join Pliant Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - GuruFocus.com

Mar 21, 2025

Mar 20, 2025

Pliant Therapeutics’ (PLRX) “Neutral” Rating Reaffirmed at HC Wainwright - The AM Reporter

Mar 20, 2025